NCT05468359 Safety and Efficacy of Cyclophosphamide, Sorafenib, Bevacizumab, and Atezolizumab in Pediatric Solid Tumor Patients Status RECRUITING Phase PHASE1/PHASE2
NCT05466565 Antiviral Therapy for Patients With Liver Cancer After Surgery Status RECRUITING Phase N/A
NCT05451862 Holmium-166 Transarterial Radioembolization in Unresectable, Early Stage Hepatocellular Carcinoma. Status TERMINATED Phase NA
NCT05449860 Radiofrequency Ablation for Recurrent Hepatocellular Carcinoma With Twin Cooled-wet Electrodes Status UNKNOWN Phase NA
NCT05448677 Ezurpimtrostat Autophagy Inhibitor in Association With Atezolizumab-Bevacizumab in First Line Treatment of Unresectable Hepatocellular Carcinoma Status TERMINATED Phase PHASE2
NCT05448222 Effect of Sarcopenia on Hepatocellular Carcinoma(HCC) After Systemic Therapies Status UNKNOWN Phase N/A
NCT05444478 Microwave Ablation Simultaneously Combined With Lenavatinib for Recurrent Hepatocellular Carcinoma Status RECRUITING Phase NA
NCT05441475 A Phase 2, Open-Label Study of ABSK-011 Combined Atezolizumab or SOC in HCC Patients Status ENROLLING_BY_INVITATION Phase PHASE2
NCT05440708 A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma Status RECRUITING Phase PHASE1/PHASE2
NCT05435014 T-ACE Oil by TAE/TACE in Patients With Hepatocellular Carcinoma Status TERMINATED Phase PHASE1/PHASE2
NCT05433701 Stereotactic Body Radiotherapy Versus Radiofrequency Ablation for Unresectable, Small (≤ 3 cm) HCC Status ACTIVE_NOT_RECRUITING Phase NA
NCT05433467 CT-guided Localization for Micro Hepatocellular Carcinoma Before Surgical Resection Status RECRUITING Phase NA
NCT05432492 A Study of AK112 in Patients With Unresectable Hepatocellular Carcinoma (HCC) Status COMPLETED Phase PHASE2
NCT05431621 Establishment of Molecular Classification Models for Early Diagnosis of Digestive System Cancers Status COMPLETED Phase N/A
NCT05429866 Immunological Variables Associated to ICI Toxicity in Cancer Patients Status UNKNOWN Phase PHASE2